Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

23 Apr 2019 15:37

RNS Number : 8436W
Premier Veterinary Group PLC
23 April 2019
 

 

PREMIER VETERINARY GROUP PLC

 

NOTIFICATION OF TRANSACTIONS OF PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMR)

 

London, UK, 23 April 2019 (LSE: PVG): Premier Veterinary Group plc ("the Company") announces that it has on 26 February 2019:

 

Issued Warrants to subscribe to 230,204 ordinary shares of 10 pence each ("Ordinary Shares") in the Company to Crossroads Finance limited ("Crossroads"), a company jointly owned and controlled by Dominic Tonner, Chief Executive Officer of PVG, and his spouse;

 

Pending exercise of the warrants, there is no change to Mr Tonner's beneficial interest as a result of this transaction, this being 1,799,670 Ordinary Shares in the Company, representing 11.73% of the total voting rights of the Company.

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

 

Dominic Stephen TONNER

2

Reason for the notification

 

a)

Position/status

 

Chief Executive Officer

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Premier Veterinary Group plc

 

b)

LEI

 2138009B5L8VQUZ9A719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Warrants to subscribe for new ordinary shares of £0.10 each

 

 

 

ISIN: GB00BSZLMS59

b)

Nature of the transaction

Issue of warrants

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£0.10

230,204 shares

 

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

N/A

N/A

N/A

e)

Date of the transaction

2019-04-23

 

f)

Place of the transaction

Outside of a trading venue

 

 

For further information, please contact:

 

Premier Veterinary Group plc

Dominic Tonner, Chief Executive Officer

Andy Paull, Chief Financial Officer

 

Tel: +44 (0)117 970 4130

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFVSSVIVFIA
Date   Source Headline
17th May 201010:17 amRNSForm 8.5 (EPT/NON-RI)
14th May 201011:16 amRNSForm 8.5 (EPT/RI)
14th May 20109:36 amRNSForm 8.5 (EPT/NON-RI)
12th May 201010:39 amRNSForm 8.5 (EPT/RI)
12th May 20109:49 amRNSForm 8.5 (EPT/NON-RI)
11th May 20108:41 amRNSForm 8.5 (EPT/NON-RI)
10th May 20104:19 pmRNSForm 8.3 - [Ark Therapeutics Grp]
10th May 201010:41 amRNSForm 8.5 (EPT/NON-RI)
7th May 20102:37 pmRNSForm 8.3 - Ark Therapeutics Grp
7th May 201010:03 amRNSForm 8.5 (EPT/RI)
7th May 201010:01 amRNSForm 8.5 (EPT/NON-RI)
6th May 201012:24 pmRNSForm 8.3 - Ark Therapeutics Group PLC
6th May 20109:49 amRNSForm 8.5 (EPT/NON-RI)
5th May 201011:48 amRNSForm 8.3 - (Ark Therapeutics)
5th May 20107:00 amRNSStrategic Review
4th May 20101:54 pmRNSForm 8 (OPD) Ark Therapeutics Group
4th May 20101:36 pmRNSForm 8.5 (EPT/NON-RI)
30th Apr 20101:43 pmRNSForm 8.3 - Ark Therapeutics Group PLC
30th Apr 201012:05 pmRNSTotal Voting Rights
30th Apr 201012:03 pmRNSDirector/PDMR Shareholding
30th Apr 201011:55 amRNSForm 8 (DD) - Ark Therapeutics Group PLC
30th Apr 201010:49 amRNSForm 8.5 (EPT/RI)
29th Apr 201011:11 amRNSForm 8.5 (EPT/NON-RI)
29th Apr 201011:04 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 20102:44 pmRNSForm 8.3 - Ark Therapeutics Group plc
28th Apr 201010:31 amRNSForm 8.5 (EPT/NON-RI)
27th Apr 201011:40 amRNSForm 8.5 (EPT/RI)
26th Apr 20102:53 pmRNSForm 8.3 - ARK THERAPEUTICS
26th Apr 201012:43 pmRNSForm 8.3 - Ark Therapeutics Group plc
26th Apr 201011:30 amRNSForm 8.5 (EPT/RI)
26th Apr 20109:42 amRNSForm 8.5 (EPT/NON-RI)
23rd Apr 201011:43 amRNSForm 8.3 - ARK THERAPEUTICS
23rd Apr 201011:36 amRNSForm 8.5 (EPT/RI)
23rd Apr 201010:16 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 201011:33 amRNSForm 8.3 - ARK THERAPEUTICS
22nd Apr 201011:03 amRNSForm 8.3 - Ark Therapeutics Group Plc
22nd Apr 20109:48 amRNSForm 8.5 (EPT/RI)
21st Apr 20101:47 pmRNSForm 8.3 - ARK THERAPEUTICS
21st Apr 201012:05 pmRNSResult of AGM
21st Apr 20109:11 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20103:56 pmRNSForm 8.3 - Ark Therapeutics Group Plc
20th Apr 201012:49 pmBUSForm 8.3 - Ark Therapeutics Group plc
20th Apr 201011:37 amRNSForm 8.5 (EPT/RI)
20th Apr 20109:48 amRNSForm 8.3 - Ark Therapeutics Plc
20th Apr 20108:53 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20102:44 pmRNSForm 8.3 - Ark Therapeutics Group plc
19th Apr 201011:31 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20107:00 amRNSResearch Update
16th Apr 201010:32 amRNSEPT Disclosure
16th Apr 20109:32 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.